Medicine and Dentistry
Endoscopic Ultrasound
66%
Cholestasis
33%
Diagnosis
33%
Cholangitis
33%
Common Bile Duct
33%
Bile Duct
33%
Polyp
33%
Cystic Pancreatic Lesion
33%
Endoscopic Retrograde Cholangiopancreatography
17%
Biopsy
17%
Bile Duct Cancer
17%
Extrahepatic Bile Duct
13%
Common Bile Duct Stone
13%
Neoplasm
13%
Malignant Neoplasm
10%
Disease
10%
Fine-Needle Aspiration
7%
Biliary Tract Cancer
7%
Magnetic Resonance Cholangiopancreatography
6%
Diagnostic Imaging
6%
Epithelial Cell
6%
Surgery
6%
Informed Consent
6%
Abdominal Pain
6%
Cholangiography
6%
Endoscopic Sphincterotomy
6%
Computer Assisted Tomography
6%
Cholangiocarcinoma
6%
Pharmacology, Toxicology and Pharmaceutical Science
Atezolizumab
100%
Liver Cell Carcinoma
100%
Bevacizumab
100%
Alpha Fetoprotein
33%
Creatinine
33%
Disease
29%
Lenvatinib
26%
Diseases
20%
Solid Malignant Neoplasm
17%
Adverse Event
13%
Prothrombin
7%
Retrospective Study
6%
Keyphrases
Atezolizumab Plus Bevacizumab
66%
Medical Ultrasonics
33%
Efficacy Predictor
33%
Clinical Practice
33%
Advanced Hepatocellular Carcinoma
33%
Lenvatinib
26%
Dipstick Urinalysis
22%
Bile Duct Tumor
16%
Article Use
16%
Adverse Events
13%
White Surface
8%
Patient Informed Consent
8%
Objective Response Rate
6%
Modified Response Evaluation Criteria in Solid Tumors (mRECIST)
6%
Disease Control Rate
6%
Liver Function
6%
Rate Control
6%
Therapeutic Safety
6%
Function Response
6%
Therapeutic Efficacy
6%
Response Evaluation Criteria in Solid Tumors (RECIST)
6%
Potential Therapeutics
6%
Anti-tumor Response
6%